Dr.

Sterling Clarren Retires

After almost 40 years in the field of Fetal Alcohol Spectrum Disorder (FASD), Dr. Sterling Clarren will be retiring in April 2014. As one of the very first clinicians to recognize that alcohol exposure during pregnancy caused neurological damage, Dr. Clarren was an instrumental force in developing the field of FASD from its infancy and has been a world leader in research on this issue. He has dedicated his life to understanding the complexities of FASD and advancing the science, using that evidence to improve diagnosis, develop interventions, increase awareness and change outcomes for those living with this disability. Dr. Clarren is a Clinical Professor with the Division of Developmental Pediatrics, Department of Pediatrics, at the University of British Columbia, and an Investigator with Developmental Neurosciences and Child Health, Child & Family Research Institute. He is also a Clinical Professor of Pediatrics at the University of Washington. He received his BA from Yale University and his MD from the University of Minnesota Medical School. He then completed pediatric residency training at the University of Washington School of Medicine before going on to do fellowships in Biosciences, Dysmorphology, and Congenital Defects at the University of Washington School of Medicine. He was on the faculty at the University of Washington as the Robert A. Aldrich Professor of Pediatrics until the fall of 2004 when he assumed the role of Scientific Director of the Canada Fetal Alcohol Spectrum Disorder Research Network (CanFASD). Dr. Clarren is also a fellow of the American Academy of Pediatrics, the American Association for the Advancement of Science, a past president of the FAS study group for the Research Society on Alcoholism, past president of the West Coast Teratology Society, and a member of the Society for Pediatric Research, New York Academy of Science, the Teratology Society. Throughout his career, Dr. Clarren has published over 100 scholarly papers and been involved in initiatives at the community, provincial, regional, national and international level to address and advance the diagnosis, intervention and prevention of FASD. Through his leadership and commitment great strides have been made. CanFASD is grateful for Dr. Clarrens dedication to the field and to our organization. We will continue to consult his expertise and we will always value his contributions. Dr. Sterling Clarren will be honoured for his work at a gala at the 6th Annual International Conference on Fetal Alcohol Spectrum Disorder in British Columbia in 2015.
intervention prevention diagnostics

Together: finding answers, improving outcomes.